As Turing Pharmaceuticals grandly announced last week that Daraprim’s recent price hike from $13.50 per pill to $750 per pill…is to be “cut 50% for some hospitals”, and numerous Democrat, and now, several Republican lawmakers in Washington, D.C., are publicly calling for measures to “control the costs of drugs”, it’s time to step back from the national piling on that the US drug industry is now experiencing, and reflect…

The penalty for failing to have health insurance is going up, perhaps even higher than you expected.

Martin Shkreli is once again provoking alarm with a plan to sharply increase the price of a decades-old drug for a serious infectious disease. This time the drug treats Chagas disease, a parasitic infection that can cause potentially lethal heart problems.

Starting in January, companies employing 50 to 100 workers face complicated and seemingly contradictory new rules that will affect what kind of insurance they offer and how much they and their workers will pay for it.

Lawmakers are considering scaling back an ObamaCare tax on insurance companies as part of a year-end legislative deal.

On Monday, Covered California officials announced that 140,000 people have enrolled so far during the enrollment period that started Nov. 1. That's about halfway to the exchange's lower-end expectation of 260,000 sign-ups by the end of this open enrollment period on Jan. 31, 2016.